Ly Mee Yu

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review
    Ly Mee Yu
    Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, UK
    Trials 11:59. 2010
  2. ncbi Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study
    Ameneh Khatami
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 31:1069-73. 2012
  3. ncbi Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
    Geraldine Blanchard-Rohner
    Oxford Vaccine Group and the NIHR Oxford Biomedical Research Centre, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK
    Vaccine 30:4153-9. 2012
  4. ncbi Reporting of participant flow diagrams in published reports of randomized trials
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, Wolfson College, Linton Road, Oxford, UK
    Trials 12:253. 2011
  5. ncbi A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods
    Gary S Collins
    Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK
    J Clin Epidemiol 66:268-77. 2013
  6. ncbi Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
    Ameneh Khatami
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
    Vaccine 30:2831-8. 2012
  7. ncbi Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial
    Nicoletta Gossger
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    JAMA 307:573-82. 2012
  8. ncbi Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells
    Elizabeth A Clutterbuck
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
    J Infect Dis 205:1408-16. 2012
  9. ncbi The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, Linton Road, Oxford OX2 6UD
    BMJ 340:c723. 2010
  10. ncbi Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting
    Gary S Collins
    Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, OX2 6UD, UK
    BMC Med 9:103. 2011

Detail Information

Publications12

  1. ncbi Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review
    Ly Mee Yu
    Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, UK
    Trials 11:59. 2010
    ..To evaluate the use and reporting of adjusted analysis in randomised controlled trials (RCTs) and compare the quality of reporting before and after the revision of the CONSORT Statement in 2001...
  2. ncbi Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study
    Ameneh Khatami
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 31:1069-73. 2012
    ..We evaluated whether these differences persisted to later childhood, following a preschool booster of DTaP-IPV at 3½ years of age...
  3. ncbi Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
    Geraldine Blanchard-Rohner
    Oxford Vaccine Group and the NIHR Oxford Biomedical Research Centre, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK
    Vaccine 30:4153-9. 2012
    ..That an inhibitory effect of baseline antibody cannot be assumed a priori is supported by observations in animal models, which show that baseline antibody can both suppress or enhance the antibody response to a specific antigen...
  4. ncbi Reporting of participant flow diagrams in published reports of randomized trials
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, Wolfson College, Linton Road, Oxford, UK
    Trials 12:253. 2011
    ..We assessed the type and completeness of information reported in CONSORT (Consolidated Standards of Reporting Trials) flow diagrams published in current reports of randomized trials...
  5. ncbi A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods
    Gary S Collins
    Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK
    J Clin Epidemiol 66:268-77. 2013
    ....
  6. ncbi Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations
    Ameneh Khatami
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
    Vaccine 30:2831-8. 2012
    ..We evaluated the persistence of bactericidal antibodies through early childhood, following infant immunisation with varying schedules of MenACWY-CRM(197) vaccine...
  7. ncbi Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial
    Nicoletta Gossger
    Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre and Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    JAMA 307:573-82. 2012
    ..In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB) remains a major cause of invasive disease in early childhood in developed countries...
  8. ncbi Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells
    Elizabeth A Clutterbuck
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
    J Infect Dis 205:1408-16. 2012
    ..It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), although highly effective in infants, offer any immunological advantages over 23vP in adults...
  9. ncbi The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed
    Sally Hopewell
    Centre for Statistics in Medicine, University of Oxford, Linton Road, Oxford OX2 6UD
    BMJ 340:c723. 2010
    ....
  10. ncbi Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting
    Gary S Collins
    Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, OX2 6UD, UK
    BMC Med 9:103. 2011
    ....
  11. ncbi Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine
    Philip C S de Whalley
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    Pediatr Infect Dis J 30:e203-8. 2011
    ..Adolescents are at particular risk from meningococcal disease, therefore they might benefit from a booster dose of vaccine. The duration of serologic response to such a booster in adolescents is unknown...
  12. ncbi Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART)
    David P Taggart
    Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
    Eur Heart J 31:2470-81. 2010
    ..The Arterial Revascularisation Trial (ART) is a randomized trial of BIMA vs. SIMA, with a primary outcome of survival at 10 years. This paper reports mortality, morbidity, and resource use data at 1 year...